首页 > 最新文献

La Revue du praticien最新文献

英文 中文
Is nature in the city beneficial to health? 城市里的大自然对健康有益吗?
Pub Date : 2025-12-01
Mathilde Pascal, Philippe Pirard
{"title":"Is nature in the city beneficial to health?","authors":"Mathilde Pascal, Philippe Pirard","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1061-1062"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overconfidence in generative chatbots: is doctors'independance at risk ? 与性发育障碍有关的医疗决定:哪些新的伦理问题?
Pub Date : 2025-12-01
Nicolas Santiago, Pierre Le Coz
{"title":"Overconfidence in generative chatbots: is doctors'independance at risk ?","authors":"Nicolas Santiago, Pierre Le Coz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1059-1060"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Adult Pain Management in the Emergency Department]. [急诊科成人疼痛管理]。
Pub Date : 2025-12-01
Anna Bouchara, Virginie-Eve Lvovschi

The "Assessment - Acute Treatment - Reassessment - Relay" approach is still the basis of acute pain management for adults in the emergency department, and intravenous morphine titration remains the cornerstone of severe pain management. However, new recommendations, incorporating all the latest scientific and contextual developments, have led to challenge its place, and to modify the treatment approach. As a general rule, an initial protocol at triage should be followed by multimodal, individualized management for each patient, taking into account the possibility of induced pain, and analgesic relays after the emergency stay should be adapted to the new benefit/risk balance of opioids (from all classes) especially for ambulatory patients.

“评估-急性治疗-重新评估-中转”的方法仍然是急诊成人急性疼痛管理的基础,静脉注射吗啡滴注仍然是严重疼痛管理的基石。然而,新的建议,结合所有最新的科学和背景发展,导致挑战其地位,并修改治疗方法。作为一般规则,分诊时的初始方案应遵循对每位患者的多模式、个体化管理,并考虑到诱发疼痛的可能性,急诊住院后的镇痛继电器应适应阿片类药物(来自所有类别)的新获益/风险平衡,特别是对门诊患者。
{"title":"[Adult Pain Management in the Emergency Department].","authors":"Anna Bouchara, Virginie-Eve Lvovschi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The \"Assessment - Acute Treatment - Reassessment - Relay\" approach is still the basis of acute pain management for adults in the emergency department, and intravenous morphine titration remains the cornerstone of severe pain management. However, new recommendations, incorporating all the latest scientific and contextual developments, have led to challenge its place, and to modify the treatment approach. As a general rule, an initial protocol at triage should be followed by multimodal, individualized management for each patient, taking into account the possibility of induced pain, and analgesic relays after the emergency stay should be adapted to the new benefit/risk balance of opioids (from all classes) especially for ambulatory patients.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1051-1058"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Venous diseases of the liver: what are we talking about?] 肝脏静脉疾病:我们在谈论什么?]
Pub Date : 2025-12-01
Audrey Payancé, Juliette Soret-Dulphy

Vascular diseases of the liver include damage to arterial and venous vessels, both hepatic and perihepatic. The main venous forms are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT) and porto-sinusoidal vascular disease (PSVD), defined by the location of the thrombotic obstruction. BCS corresponds to an obstruction of the hepatic veins, PVT to an obstruction of the portal vein with a risk of cavernoma, and PSVD to damage the intrahepatic microcirculation without cirrhosis. These rare diseases mainly affect young adults and cause portal hypertension in the absence of underlying liver disease. Myeloproliferative neoplasms are a common risk factor, among other systemic causes (coagulation disorders, antiphospholipid antibodies, infections, pregnancy) or local causes (inflammation, surgery).

肝脏血管疾病包括肝和肝周动脉和静脉血管的损害。主要的静脉形式是Budd-Chiari综合征(BCS)、门静脉血栓形成(PVT)和门窦血管疾病(PSVD),由血栓阻塞的位置来定义。BCS对应肝静脉梗阻,PVT对应门静脉梗阻,有发生海绵状瘤的风险,PSVD对应肝内微循环受损,无肝硬化。这些罕见疾病主要影响年轻人,在没有潜在肝脏疾病的情况下引起门静脉高压症。骨髓增生性肿瘤是一个常见的危险因素,其他系统性原因(凝血功能障碍、抗磷脂抗体、感染、妊娠)或局部原因(炎症、手术)。
{"title":"[Venous diseases of the liver: what are we talking about?]","authors":"Audrey Payancé, Juliette Soret-Dulphy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Vascular diseases of the liver include damage to arterial and venous vessels, both hepatic and perihepatic. The main venous forms are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT) and porto-sinusoidal vascular disease (PSVD), defined by the location of the thrombotic obstruction. BCS corresponds to an obstruction of the hepatic veins, PVT to an obstruction of the portal vein with a risk of cavernoma, and PSVD to damage the intrahepatic microcirculation without cirrhosis. These rare diseases mainly affect young adults and cause portal hypertension in the absence of underlying liver disease. Myeloproliferative neoplasms are a common risk factor, among other systemic causes (coagulation disorders, antiphospholipid antibodies, infections, pregnancy) or local causes (inflammation, surgery).</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1078-1080"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recommendations for high-altitude travel in individuals with cardiorespiratory diseases]. [心肺疾病患者的高海拔旅行建议]。
Pub Date : 2025-12-01
Emeric Stauffer, Pierre Tankere, Romain Carin, Philippe Connes, Elie Nader

The World Tourism Organization estimates that between 195 and 375 million people traveled to high altitudes in 2019. The high prevalence of cardiorespiratory diseases in the general population, combined with the increasing number of elderly travelers, suggests that a significant proportion of these individuals may have underlying health conditions. Hypoxia, the main physiological challenge at high altitude, requires adaptive responses from the cardiorespiratory system, which are often impaired in patients with cardiac or pulmonary diseases. This population is at particular risk of decompensation and altitude intolerance symptoms. Therefore, a thorough medical assessment, including evaluation of comorbidities and consultation with a mountain medicine specialist, may be essential prior to high-altitude travel or long-haul flights.

世界旅游组织估计,2019年有1.95亿至3.75亿人前往高海拔地区。一般人群中心血管疾病的高流行率,加上老年旅行者人数的增加,表明这些人中很大一部分可能有潜在的健康问题。缺氧是高海拔地区的主要生理挑战,需要心肺系统做出适应性反应,而心肺系统在患有心脏或肺部疾病的患者中往往受损。这一人群特别容易出现代偿失调和高原不耐受症状。因此,在进行高海拔旅行或长途飞行之前,可能必须进行彻底的医疗评估,包括评估合并症和咨询山地医学专家。
{"title":"[Recommendations for high-altitude travel in individuals with cardiorespiratory diseases].","authors":"Emeric Stauffer, Pierre Tankere, Romain Carin, Philippe Connes, Elie Nader","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The World Tourism Organization estimates that between 195 and 375 million people traveled to high altitudes in 2019. The high prevalence of cardiorespiratory diseases in the general population, combined with the increasing number of elderly travelers, suggests that a significant proportion of these individuals may have underlying health conditions. Hypoxia, the main physiological challenge at high altitude, requires adaptive responses from the cardiorespiratory system, which are often impaired in patients with cardiac or pulmonary diseases. This population is at particular risk of decompensation and altitude intolerance symptoms. Therefore, a thorough medical assessment, including evaluation of comorbidities and consultation with a mountain medicine specialist, may be essential prior to high-altitude travel or long-haul flights.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1125-1131"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screening for chronic kidney disease in children]. [儿童慢性肾脏疾病筛查]。
Pub Date : 2025-12-01
Jade Cognard, Christine Pietrement

Chronic kidney disease (CKD) in children has an epidemiology that differs significantly from that in adults. Its main causes vary with age with a predominance of congenital anomalies of the kidney and the urinary tract. Early diagnosis is essential to prevent complications affecting growth, cognition, and long-term cardiovascular health, and to avoid, or at least to slow, progression to end-stage renal disease. Specific clinical contexts warrant targeted screening: family history, perinatal abnormalities, at-risk conditions, or suggestive clinical signs. Screening relies on simple tools such as growth charts, dipstick urinalysis, blood pressure measurement, glomerular filtration rate estimation, and renal ultrasound. The general practitioner plays a key role in the early detection of CKD, and in ensuring early referral to pediatric nephrology, helping to preserve nephron mass and improve long-term outcomes.

儿童慢性肾脏疾病(CKD)的流行病学与成人有很大不同。其主要原因随年龄的不同而不同,主要是肾脏和泌尿道的先天性异常。早期诊断对于预防影响生长、认知和长期心血管健康的并发症,避免或至少减缓进展为终末期肾脏疾病至关重要。特定的临床背景需要有针对性的筛查:家族史、围产期异常、高危状况或暗示性临床症状。筛查依靠简单的工具,如生长图、尿量尺分析、血压测量、肾小球滤过率估计和肾脏超声。全科医生在CKD的早期发现、确保早期转诊到儿科肾脏科、帮助保存肾单位质量和改善长期预后方面发挥着关键作用。
{"title":"[Screening for chronic kidney disease in children].","authors":"Jade Cognard, Christine Pietrement","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chronic kidney disease (CKD) in children has an epidemiology that differs significantly from that in adults. Its main causes vary with age with a predominance of congenital anomalies of the kidney and the urinary tract. Early diagnosis is essential to prevent complications affecting growth, cognition, and long-term cardiovascular health, and to avoid, or at least to slow, progression to end-stage renal disease. Specific clinical contexts warrant targeted screening: family history, perinatal abnormalities, at-risk conditions, or suggestive clinical signs. Screening relies on simple tools such as growth charts, dipstick urinalysis, blood pressure measurement, glomerular filtration rate estimation, and renal ultrasound. The general practitioner plays a key role in the early detection of CKD, and in ensuring early referral to pediatric nephrology, helping to preserve nephron mass and improve long-term outcomes.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1132-1136"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Borderline personality disorder]. 边缘型人格障碍。
Pub Date : 2025-12-01
Deborah Ducasse, Émilie Olié

Borderline Personality Disorder (BPD) is common, affecting 2 to 6 % of the general population, with a high prevalence in psychiatric settings. It is characterized by emotional, relational instability and impulsivity, often associated with suicidal behaviors and comorbid disorders (anxiety, depression, addictions). Understanding BPD relies on the concept of relational hypersensitivity, rooted in an altered self-concept. The biopsychosocial approach explains its origins through the interaction between genetic vulnerability and emotional invalidation during childhood, exacerbated by trauma. Treatment primarily involves cognitive-behavioral therapies (CBT), such as Dialectical Behavior Therapy (DBT), which promote emotional regulation and reduce self-harming behaviors. Management should include thorough evaluation and education focused on relational hypersensitivity. Although limited, pharmacological treatments can address specific dimensions of BPD but require cautious prescription.

边缘型人格障碍(BPD)很常见,影响总人口的2%到6%,在精神科的发病率很高。它的特点是情绪、关系不稳定和冲动,通常与自杀行为和共病障碍(焦虑、抑郁、成瘾)有关。对BPD的理解依赖于关系超敏症的概念,这种概念根植于一种改变了的自我概念。生物-心理-社会方法解释了其起源,通过遗传脆弱性和儿童时期的情感失能之间的相互作用,并因创伤而加剧。治疗主要涉及认知行为疗法(CBT),如辩证行为疗法(DBT),促进情绪调节和减少自我伤害行为。管理应包括全面的评估和教育,重点是关系的超敏感性。虽然有限,但药物治疗可以解决BPD的特定方面,但需要谨慎的处方。
{"title":"[Borderline personality disorder].","authors":"Deborah Ducasse, Émilie Olié","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Borderline Personality Disorder (BPD) is common, affecting 2 to 6 % of the general population, with a high prevalence in psychiatric settings. It is characterized by emotional, relational instability and impulsivity, often associated with suicidal behaviors and comorbid disorders (anxiety, depression, addictions). Understanding BPD relies on the concept of relational hypersensitivity, rooted in an altered self-concept. The biopsychosocial approach explains its origins through the interaction between genetic vulnerability and emotional invalidation during childhood, exacerbated by trauma. Treatment primarily involves cognitive-behavioral therapies (CBT), such as Dialectical Behavior Therapy (DBT), which promote emotional regulation and reduce self-harming behaviors. Management should include thorough evaluation and education focused on relational hypersensitivity. Although limited, pharmacological treatments can address specific dimensions of BPD but require cautious prescription.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1121-1124"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transposition of the great arteries congenitally corrected 大动脉转位先天矫正
Pub Date : 2025-12-01
Sara Aouame
{"title":"Transposition of the great arteries congenitally corrected","authors":"Sara Aouame","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1118"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[When should vascular liver disease be considered?] 什么时候应该考虑血管性肝病?]
Pub Date : 2025-12-01
Jérôme Dumortier, Maxime Ronot, Aurélie Beaufrère

Vascular liver diseases (VLD) are rare and their diagnosis can be difficult and late, leading to a delay in treatment. Diagnosis is most often multidisciplinary, involving primarily the clinician but also the radiologist and pathologist. In all cases, attention should be drawn to the absence of the usual causes of liver disease; conversely, a context of pathology associated with VLD may be a suggestive factor. The two main ways in which porto-sinusoidal vascular disease is discovered are unexplained abnormal liver tests and portal hypertension (PHT) without cirrhosis. In the case of acute splanchnic thrombosis (mainly portal), the main symptom is abdominal pain. The intensity of symptoms varies greatly, and the diagnosis may be overlooked and established late, at the stage of portal cavernoma and possibly complications of PHT. Budd-Chiari syndrome can mimic any acute or chronic liver disease, with the most common presentation being ascites/hepatomegaly/abdominal pain. Many clinical situations should raise the suspicion of VLD, which is based on dialogue between the clinician, radiologist, and pathologist. Early diagnosis allows for optimal patient management, particularly through anticoagulant therapy and treatment of PHT.

血管性肝病(VLD)是罕见的,他们的诊断可能是困难和晚,导致治疗延误。诊断通常是多学科的,主要涉及临床医生,也包括放射科医生和病理学家。在所有情况下,都应注意没有引起肝病的常见原因;相反,与VLD相关的病理背景可能是一个暗示性因素。发现门窦血管疾病的两种主要方式是不明原因的异常肝脏检查和无肝硬化的门脉高压。急性内脏血栓形成(以门静脉为主),主要症状为腹痛。症状的强度差别很大,诊断可能被忽视和确立较晚,在门静脉海绵瘤阶段和可能的PHT并发症。Budd-Chiari综合征可以模拟任何急性或慢性肝脏疾病,最常见的表现是腹水/肝肿大/腹痛。许多临床情况应该引起VLD的怀疑,这是基于临床医生、放射科医生和病理学家之间的对话。早期诊断可以实现最佳的患者管理,特别是通过抗凝治疗和PHT治疗。
{"title":"[When should vascular liver disease be considered?]","authors":"Jérôme Dumortier, Maxime Ronot, Aurélie Beaufrère","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Vascular liver diseases (VLD) are rare and their diagnosis can be difficult and late, leading to a delay in treatment. Diagnosis is most often multidisciplinary, involving primarily the clinician but also the radiologist and pathologist. In all cases, attention should be drawn to the absence of the usual causes of liver disease; conversely, a context of pathology associated with VLD may be a suggestive factor. The two main ways in which porto-sinusoidal vascular disease is discovered are unexplained abnormal liver tests and portal hypertension (PHT) without cirrhosis. In the case of acute splanchnic thrombosis (mainly portal), the main symptom is abdominal pain. The intensity of symptoms varies greatly, and the diagnosis may be overlooked and established late, at the stage of portal cavernoma and possibly complications of PHT. Budd-Chiari syndrome can mimic any acute or chronic liver disease, with the most common presentation being ascites/hepatomegaly/abdominal pain. Many clinical situations should raise the suspicion of VLD, which is based on dialogue between the clinician, radiologist, and pathologist. Early diagnosis allows for optimal patient management, particularly through anticoagulant therapy and treatment of PHT.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1081-1085"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modesty and scientific publications 谦虚与科学出版物
Pub Date : 2025-12-01
Philippe Charlier
{"title":"Modesty and scientific publications","authors":"Philippe Charlier","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 10","pages":"1072-1074"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
La Revue du praticien
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1